scholarly journals Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells

Oncogenesis ◽  
2014 ◽  
Vol 3 (5) ◽  
pp. e104-e104 ◽  
Author(s):  
S Hibino ◽  
Y Saito ◽  
T Muramatsu ◽  
A Otani ◽  
Y Kasai ◽  
...  
2011 ◽  
Vol 286 (18) ◽  
pp. 15698-15706 ◽  
Author(s):  
Kei Suzuki ◽  
Chitose Oneyama ◽  
Hironobu Kimura ◽  
Shoji Tajima ◽  
Masato Okada

The transmembrane adaptor protein Cbp (or PAG1) functions as a suppressor of Src-mediated tumor progression by promoting the inactivation of Src. The expression of Cbp is down-regulated in Src-transformed cells and in various human cancer cells, suggesting a potential role for Cbp as a tumor suppressor. However, the mechanisms underlying the down-regulation of Cbp remain unknown. The present study shows that Cbp expression is down-regulated by epigenetic histone modifications via the MAPK/PI3K pathway. In mouse embryonic fibroblasts, transformation by oncogenic Src and Ras induced a marked down-regulation of Cbp expression. The levels of Cbp expression were inversely correlated with the activity of MEK and Akt, and Cbp down-regulation was suppressed by inhibiting MEK and PI3K. Src transformation did not affect the stability of Cbp mRNA, the transcriptional activity of the cbp promoter, or the DNA methylation status of the cbp promoter CpG islands. However, Cbp expression was restored by treatment with histone deacetylase (HDAC) inhibitors and by siRNA-mediated knockdown of HDAC1/2. Src transformation significantly decreased the acetylation levels of histone H4 and increased the trimethylation levels of histone H3 lysine 27 in the cbp promoter. EGF-induced Cbp down-regulation was also suppressed by inhibiting MEK and HDAC. Furthermore, the inhibition of MEK or HDAC restored Cbp expression in human cancer cells harboring Cbp down-regulation through promoter hypomethylation. These findings suggest that Cbp down-regulation is primarily mediated by epigenetic histone modifications via oncogenic MAPK/PI3K pathways in a subset of cancer cells.


Oncogene ◽  
2020 ◽  
Author(s):  
Ann-Kathrin Schmidt ◽  
Karoline Pudelko ◽  
Jan-Eric Boekenkamp ◽  
Katharina Berger ◽  
Maik Kschischo ◽  
...  

Abstract Whole chromosome instability (W-CIN) is a hallmark of human cancer and contributes to the evolvement of aneuploidy. W-CIN can be induced by abnormally increased microtubule plus end assembly rates during mitosis leading to the generation of lagging chromosomes during anaphase as a major form of mitotic errors in human cancer cells. Here, we show that loss of the tumor suppressor genes TP53 and TP73 can trigger increased mitotic microtubule assembly rates, lagging chromosomes, and W-CIN. CDKN1A, encoding for the CDK inhibitor p21CIP1, represents a critical target gene of p53/p73. Loss of p21CIP1 unleashes CDK1 activity which causes W-CIN in otherwise chromosomally stable cancer cells. Consequently, induction of CDK1 is sufficient to induce abnormal microtubule assembly rates and W-CIN. Vice versa, partial inhibition of CDK1 activity in chromosomally unstable cancer cells corrects abnormal microtubule behavior and suppresses W-CIN. Thus, our study shows that the p53/p73 - p21CIP1 tumor suppressor axis, whose loss is associated with W-CIN in human cancer, safeguards against chromosome missegregation and aneuploidy by preventing abnormally increased CDK1 activity.


2013 ◽  
Vol 41 (11) ◽  
pp. 5614-5625 ◽  
Author(s):  
Ji Young Lee ◽  
Hyo Jeong Kim ◽  
Nal Ae Yoon ◽  
Won Hyeok Lee ◽  
Young Joo Min ◽  
...  

2003 ◽  
Vol 278 (23) ◽  
pp. 20475-20479 ◽  
Author(s):  
Prasad V. Jallepalli ◽  
Christoph Lengauer ◽  
Bert Vogelstein ◽  
Fred Bunz

Neoplasia ◽  
2006 ◽  
Vol 8 (12) ◽  
pp. 1003-1010 ◽  
Author(s):  
Meiko Takahashi ◽  
Takanobu Yoshimoto ◽  
Masayuki Shimoda ◽  
Tomoya Kono ◽  
Masayuki Koizumi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document